← Leaderboards
Henrik Larsson
Trustees Of Indiana University
$849,452
Attributed
$1,698,903
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $442.6K · FY2014–17$500K$375K$250K$125K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$1,698,903 · 1
By mechanism
R01$1,698,903 · 1
Top collaborators
- Brian M D'Onofrio4 shared
Most similar at Trustees Of Indiana University
Same institution · by research overlap
- Brea Louise Perry$8,213,559
- Paul Lichtenstein$669,611
- Lauren Marie O'Reilly$139,072
- Quetzal Athena Class$83,360
- Kelly Lynn Donahue$83,180
Others in their field
Top investigators on “Indexing”
- David R. Weir · University Of Michigan At Ann Arbor$377,916,870
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$60,328,349
- Michael Leo Leblanc · Fred Hutchinson Cancer Research Center$53,053,753
- Susan Abushakra · Alzheon, Inc.$47,265,244
Research focus
IndexingAdverse OutcomeImpulsivityInattentionBaseBenefits And RisksFoundationsHyperactive BehaviorHeterogeneityFunctional OutcomesData SetDesignDevelopmental Disease/DisorderDiagnosisBipolar DisorderAdverse EffectsAlcohol Or Other Drugs UseEpilepsyEtiologyCohortExperimental DesignsAttention Deficit Hyperactivity DisorderFollow-UpInnovation
Grant awards (4)
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$408,990
R01 · FY2017 · MH
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$442,603
R01 · FY2016 · MH
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$408,990
R01 · FY2015 · MH
Risks and Benefits of ADHD Medication for Psychiatric and Neurologic Problems$438,320
R01 · FY2014 · MH